摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-dehydroaspidospermidine

中文名称
——
中文别名
——
英文名称
1,2-dehydroaspidospermidine
英文别名
(+/-)-dehydroaspidospermidine;(1R,12S,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,8-tetraene
1,2-dehydroaspidospermidine化学式
CAS
——
化学式
C19H24N2
mdl
——
分子量
280.413
InChiKey
FGFBHTJUUGUSCK-FHWLQOOXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    15.6
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,2-dehydroaspidospermidine乙酸酐 、 copper(II) sulfate 、 作用下, 以 溶剂黄146 为溶剂, 反应 18.5h, 生成 (+/-)-1-formyl-1-demethylvallesamidine
    参考文献:
    名称:
    Hajicek, Josef; Trojanek, Jan, Collection of Czechoslovak Chemical Communications, 1986, vol. 51, # 8, p. 1731 - 1742
    摘要:
    DOI:
  • 作为产物:
    描述:
    4a-ethyl-7-3,4,4a,5,7,11c-hexahydro-1H-pyrido[3,2-c]carbazol-6(2H)-one 在 lithium aluminium tetrahydride 、 potassium carbonate 作用下, 以 1,4-二氧六环 为溶剂, 反应 18.33h, 生成 1,2-dehydroaspidospermidine
    参考文献:
    名称:
    Synthesis of eburnamonine and dehydroaspidospermidine
    摘要:
    DOI:
    10.1021/jo00244a020
点击查看最新优质反应信息

文献信息

  • ‘Aromatic ring umpolung’, a rapid access to the main core of several natural products
    作者:Kimiaka C. Guérard、Cyrille Sabot、Marc-André Beaulieu、Marc-André Giroux、Sylvain Canesi
    DOI:10.1016/j.tet.2010.03.096
    日期:2010.7
    substituted phenols in the presence of (diacetoxyiodo)benzene promotes the formation of a phenoxenium ion, a very electrophilic species able to react with various nucleophiles leading rapidly to a plethora of different cores present in natural products via several novel oxidative processes. This strategy fits within the concept of ‘aromatic ring umpolung’; in this paper a personal account by our laboratory
    在(二乙酰氧基碘)苯存在下处理各种取代的苯酚会促进苯氧en离子的形成,苯氧en离子是一种非常亲电的物种,能够与各种亲核试剂反应,通过几种新颖的氧化过程迅速导致天然产物中存在过多的不同核心。该策略符合“芳香环保护”的概念;本文描述了我们实验室对此主题的个人描述。
  • Thermal rearrangements of some indole alkaloid derivatives
    作者:Georgette Hugel、Jean Lévy
    DOI:10.1016/s0040-4020(01)91247-5
    日期:1984.1
    thermolysis conditions, several compounds with an “aspidosperma” framework rearranged to “vinca” derivatives. Thus (-)1,2-dehydroaspidospermidine (4) rearranged to (-) gave vincane 14. Compound 6 rearranged to vincamine (13a) and 16-epi vincamine (13b) under either condition ; increasing the temperature resulted in formation of apovincamine (19) (pyrolysis) or vincamone thermolysis).
    在静态和流动热解条件下,几种具有“曲霉”构架的化合物都重新排列为“长春花”衍生物。因此,(-)1,2-脱氢天冬酰胺亚胺(4)重排为(-),得到长庚烷14。在任一条件下,化合物6重排为长庚胺(13a)和16-表长庚胺(13b);升高温度会导致形成载脂蛋白(19)(热解)或长春花碱热解)。
  • Unified Strategy to Monoterpene Indole Alkaloids: Total Syntheses of (±)-Goniomitine, (±)-1,2-Dehydroaspidospermidine, (±)-Aspidospermidine, (±)-Vincadifformine, and (±)-Kopsihainanine A
    作者:Olivier Wagnières、Zhengren Xu、Qian Wang、Jieping Zhu
    DOI:10.1021/ja509329x
    日期:2014.10.22
    Total syntheses of (±)-goniomitine, (±)-1,2-dehydroaspidospermidine, (±)-aspidospermidine, (±)-vincadifformine, and (±)-kopsihainanine A were achieved featuring two common key steps: (1) a palladium-catalyzed decarboxylative vinylation that provides quick access to cyclopentene intermediates containing all of the carbons present in the natural products and (2) an integrated oxidation/reduction/cyclization
    (±)-goniomitine、(±)-1,2-dehydroaspidospermidine、(±)-aspidospermidine、(±)-vincadifformine 和 (±)-kopsihainanine A 的全合成是通过两个常见的关键步骤实现的:(1) a钯催化的脱羧乙烯基化,可快速获得包含天然产物中存在的所有碳的环戊烯中间体和 (2) 用于骨架重组的综合氧化/还原/环化 (iORC) 序列,将环戊烯转化为五环结构天然产品。通过对 iORC 底物加入几何约束,可以控制环化过程的化学选择性(C7 与 N1 环化)和立体选择性(反式与顺式稠环系统)。
  • A unified synthesis of topologically diverse <i>Aspidosperma</i> alkaloids through divergent iminium-trapping
    作者:Marco V. Mijangos、Luis D. Miranda
    DOI:10.1039/c8ob02621a
    日期:——
    therefrom, between three different reaction paths: N(1) vs. C(3) cyclization (indole numbering) vs. over-reduction. Moreover, a catalytic carbene insertion for direct C(3)–H indole functionalization is reported for the first time in an approach to goniomitine (4), and a following tandem ester reduction/iminium generation/cyclization secured its tetracyclic system. The development of a highly diastereoselective
    从单一的分子支架,即吲哚-戊内酰胺6合成了5种曲霉生物碱,其中包括5种曲霉碱,长春花碱,长春花碱,长春新碱和槲皮胺。这种常见的中间体可以发散地操纵,通过对影响亚胺离子由其衍生的化学-选择性的构象和电子约束掺入,三个不同的反应路径之间:Ñ(1)VS。C(3)环化(吲哚编号)与。过度减少。此外,催化卡宾插入用于直接Ç(3)–H吲哚功能化是首次报道了对性腺素(4)的方法,随后的串联酯还原/亚胺生成/环化确保了其四环系统。一个高度非对映一锅半还原/环化/去保护过程的发展,以获得顺式-pyridocarbazole直接允许五环的合成白坚木属生物碱1,2,和3。
  • Synthetic Applications of 2-(1,3-Dithian-2-yl)indoles. 7. Synthesis of Aspidospermidine
    作者:Pilar Forns、Anna Diez、Mario Rubiralta
    DOI:10.1021/jo9609900
    日期:1996.1.1
    based on building ring E on the pyridocarbazole [ABCD] ring structure, is reported. The preparation of the pyridocarbazole framework of Aspidosperma alkaloids is a new three-step synthetic application of 2-(1,3-dithian-2-yl)indoles. A tandem conjugate addition-alkylation reaction starting from indolyldithiane (4), 3-methylenelactam 6, and EtI yields the adduct 17. Treatment of lactam 17 with DIBALH leads
    报道了一种基于吡啶并咔唑[ABCD]环结构上的环E合成生物碱asposspermidine(1)的新方法。香豆碱生物碱的吡啶咔唑骨架的制备是2-(1,3-二噻二-2-基)吲哚的三步合成新应用。从吲哚基二硫醚(4),3-亚甲基内酰胺6和EtI开始的串联共轭加成-烷基化反应产生加合物17。用DIBALH处理内酰胺17导致萘并吲哚18的形成。化合物18在AcOH水溶液中异构化,得到吡啶并咔唑3。最后,环E的闭合和随后的二噻吩环的还原产生了asposspermidine。制备吡啶并咔唑2和10作为模型。
查看更多

同类化合物

长春立辛 长春新碱M1 脱乙酰基文多灵 罗西定碱 温都罗新 文多灵 它波宁盐酸盐 它勃宁 Ervamycine; 11-甲氧基水甘草碱 4',5'-二去氢-4'-脱氧-2',19'-二氧代-2',19'-仲长春碱 11-羟基他波宁 (-)-14,15-didehydroaspidospermidine 4-deacetyl-4-propoxylvindoline hydroxyvinamidine 4-deacetyl-4-butoxylvindoline 4-deacetyl-4-(cyclohexanecarbonyl)oxyvindoline vinamidine jerantinine A acetate N-[[(1R,9R,12R,14S,19R)-14-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6-trien-11-ylidene]amino]-4-methylbenzenesulfonamide 16-methoxy-1-methyl-6,7-didehydro-aspidospermidin-4-one (+)-20R-1,2-dehydro-Ψ-aspidospermidine methyl (1R,9R,10S,12S,19S)-12-ethenyl-8,16-diazahexacyclo[10.6.1.01,9.02,7.08,10.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate (1R,9R,12R,19R)-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6-triene-11,17-dione methyl (1R,9R,10S,12R,19S)-12-ethyl-8,16-diazahexacyclo[10.6.1.01,9.02,7.08,10.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate 3-Oxo-11-methoxytabersonine Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12beta,19alpha)- melodinine P N-methyltabersonine 14,15-didehydro-16-hydroxy-<3H>indole ent-N(1)-methyl-14,15-didehydroaspidospermidine vindoline hydrochloride Mbid (3aS,5R,10bR,12bS)-5-Chloro-3a-ethyl-12-oxo-2,3,3a,4,5,11,12,12b-octahydro-1H-6,12a-diaza-indeno[7,1-cd]fluorene-5-carboxylic acid methyl ester (3aS,5R,10bR,12R,12bS)-5-Chloro-12-cyano-3a-ethyl-2,3,3a,4,5,11,12,12b-octahydro-1H-6,12a-diaza-indeno[7,1-cd]fluorene-5-carboxylic acid methyl ester (3aS,5aR,10bR,12bR)-6-Ethyl-2,3,3a,5a,6,12b-hexahydro-1H,5H-6,12a-diaza-indeno[7,1-cd]fluorene-4,12-dione jerantinine A jerantinine C 10-O-methyljerantinine A baloxine 2βH,3αH-tubersonine methyl 15-bromo-2,3,6,7-tetrahydro-(5α,12β,19α)-aspidospermidine-3-carboxylate methyl 15-bromo-6,7-didehydro-(2β,5α,12β,19α)-aspidospermidine-3α-carboxylate 2,3-didehydro-20,21-dinor-aspidospermidine-3-carboxylic acid methyl ester methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(1R,3S,14R)-18-ethyl-3-methoxycarbonyl-14-[[(2S)-2-methoxycarbonylpyrrolidin-1-yl]methyl]-5,16-diazatetracyclo[14.3.1.04,12.06,11]icosa-4(12),6,8,10,18-pentaen-3-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate 20-deethyl-17-ethoxy-1-(p-tolylsulfonyl)-2,16,17,20-tetradehydroaspidospermidine 3α-acetonyl-tabersonine 20-desethyl-17-formyl-5-oxo-16,17-dehydroaspidospermidine Alkaloid XC-99 16-Chloro-1-dehydrovincadifformine Methyl 11-acetyloxy-12-ethyl-4-[(Z)-1-(16-ethyl-16-hydroxy-3,13-diazatetracyclo[11.2.2.02,10.04,9]heptadeca-2(10),4,6,8-tetraen-15-yl)-3-methoxy-3-oxoprop-1-en-2-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate